News Archives - Page 7 of 11 - Buhlmann Diagnostics Corp

Category: News

From BÜHLMANN Quantum Blue® to fCAL turbo® Follow the Evolution of Calprotectin Testing at James Cook University Hospital

Mr. Andrew Teggert, Clinical Scientist, James Cook University Hospital with SIEMENS ADVIA Chemistry XPT BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada License: 96808 An interview with Mr. Andrew Teggert, Clinical Scientist, James Cook University Hospital, Middlesbrough. At the largest hospital in Tees Valley,
Continue Reading

Join Us at CSCC 2018 in Ottowa!

Canadian Society for Clinical Chemists (CSCC) 2018 BUHLMANN Diagnostics Corp  Booth: #410 June 03 - 06, 2018 | Fairmont Château Laurier Hotel. | Ottawa, ON Learn More Come by our booth to get an update on our Calprotectin,Therapeutic Drug Monitoring, Chemistry, Neuroimmunology, and Cellular Allergy portfolios Calprotectin and TDM: IBDoc®, the ONLY in-vitro diagnostic POC and home testing
Continue Reading

Connect with BUHLMANN at DDW 2018

Digestive Diseases Week (DDW) 2018 BUHLMANN Diagnostics Corp  Booth: #2347 June 02-05, 2018 | Walter E. Washington Convention Center | Washington, DC Learn More Come by our booth to get an update on our Calprotectin and Therapeutic Drug Monitoring product portfolio: Quantum Blue® platform offering rapid and quantitative results for fecal calprotectin, serum calprotectin, CRP and serum infliximab trough levels  (Additional trough level
Continue Reading

BUHLMANN LabSense News Winter 2018 Edition

BUHLMANN Diagnostics Corp is proud to release the sixth edition of our newsletter. View the latest information, new happenings, products highlights, citations, and promotions in the BUHLMANN LabSense News. Check Out LabSense News Today! What's New Introducing BAT in Food Allergy Webinar recording and eBook by Dr. Alexandra Santos as well as two new IBDoc®  Posters
Continue Reading

IBDoc Highlights

Health Canada Licence: 98903, Device class: 3  IBDoc® is not available for sale in the US. IBDoc® Calprotectin Home Test Video IBDoc®  Highlights Learn more about this calprotectin home test and check out the IBDoc®  highlights including key features, studies, posters, citations, videos, informational flyers and more! Three Easy Steps to Help Monitor IBD IBDoc® is the first
Continue Reading

The Advantages of an Immunoturbidimetric Assay for Measuring Calprotectin in Fecal Samples

 Technical Details Speed An immunoturbidimetric assay (or particle-enhanced turbidimetric immunoassay (PETIA)) for measuring Calprotectin is the fastest solution in the market with the shortest time to first result regardless of using sample batches or random access. On average, the time to first result is 7.6 min [5 min -11.6 min] with additional results every 10.86
Continue Reading

Calprotectin Assay Precision

BÜHLMANN fCAL® Assays BÜHLMANN fCAL® Assays have rock-solid performance that provide you with optimal precision to measure your results. Focus on what really matters - calprotectin results you can stand behind. Increase your efficiency and cost savings with BÜHLMANN fCAL® turbo, BÜHLMANN fCAL® ELISA, and Quantum Blue® fCAL. Precision & Linearity Data LEARN MORE Success Stories BÜHLMANN's calprotectin assays success stories
Continue Reading

Connect with BUHLMANN at AAAAI 2018

  AAAAI 2018 AMERICAN ACADEMY OF ALLERGY, ASTHMA & IMMUNOLOGY BUHLMANN Diagnostics Corp  Booth: #133 March 3 - 5, 2018 | Orange County Convention Center | Orlando, FL Learn More Come by our booth to connect with our team and discuss peanut allergy BAT testing & more! BÜHLMANN offers broad range of quality controlled allergens and mixes
Continue Reading

Clinical Applications of the Basophil Activation Test in Food Allergy

Download eBOOK Webinar Recording Webinar Overview Abstract The basophil activation test has emerged as a novel diagnostic test for food allergy. Being a functional test, it has the potential to closely resemble the clinical phenotype of patients following allergen exposure. The basophil activation test can be seen as an in vitro challenge, where instead of
Continue Reading

Connect with BUHLMANN at CDDW 2018 in Toronto

Canadian Digestive Diseases Week (CDDW) 2018 BUHLMANN Diagnostics Corp  Booth: #135 Feb 09 - 11, 2018 | The Fairmont Royal York | Toronto, ON Learn More Come by our booth to get an update on our Calprotectin and Therapeutic Drug Monitoring product portfolio: IBDoc®, the ONLY in-vitro diagnostic POC and home testing device to measure the inflammatory marker,
Continue Reading